Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

NCT00979706 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: HAART
DRUG: HAART + Immunotherapy

Sponsor

Juan A. Arnaiz